bi 1584862
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 29, 2022 (NCT05520827)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06957756 | Phase 1 | Aug 6, 2025 | Boehringer Ingelheim |
| NCT06769048 | Phase 2 | Jan 31, 2025 | Boehringer Ingelheim |
| NCT06148948 | Phase 1 | Dec 11, 2023 | Boehringer Ingelheim |
| NCT06041438 | Phase 1 | Sep 29, 2023 | Boehringer Ingelheim |
| NCT06006598 | Phase 1 | Aug 28, 2023 | Boehringer Ingelheim |
| NCT05520827 | Phase 1 | Sep 29, 2022 | Boehringer Ingelheim |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 6 | 6 | 2 | 2022 |
1 organizations
Page 1 / 1